1. ALLA AKTIER
  2. NYHETER
  3. ACARIX

Acarix

Nyheter Acarix Nyheter alla bolag

Acarix is attending 2023 BIO CEO & Investor Conference in New York City

Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO & Investor Conference in New York City, February 6-9, 2023.

The BIO CEO & Investor Conference is recognized as a premier event for C-Suite executive leaders, investors and banking communities, focusing on established as well as emerging companies, publicly traded and select private companies delivering innovation in health care.

For more information contact:
Helen Ljungdahl Round, CEO, phone +1 267 809 1225, +46 730 770283, email helen.round@acarix.com 
Christian Lindholm, CFO, phone +46 705 118333, email christian.lindholm@acarix.com

About Acarix

Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor®System uses advanced acoustics and AI-technology to rule out CAD non-invasively in less than 10 minutes, with at least 96% certainty. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, certifiedadviser@redeye.se) is Certified Advisor of Acarix. For more information, please visit www.acarix.com. 

Attachments
Acarix is attending 2023 BIO CEO & Investor Conference in New York City

Datum 2023-02-07, kl 14:26
Källa MFN
Bifogade filer
Acarix is attending 2023 BIO CEO & Investor Conference in New York City
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.